title: [Anti-parvovirus B19 IgG antibody prevalence in pregnant women during antenatal follow-up and cases of non-immune hydropsis fetalis due to parvovirus B19, in the City of Rio de Janeiro].
abstract: With the aim of measuring the prevalence of anti-parvovirus B19 IgG antibodies during pregnancy up to 24 weeks of gestation and detecting cases of nonimmune hydrops fetalis, 249 sera from pregnant women attending a reference hospital in Rio de Janeiro city, from June 2003 to November 2004 were collected. They were followed-up until the end of pregnancy, with 17 cases of fetal hydrops detected. Four cases were caused by parvovirus B19 and two of them occurred in pregnant women living in the western zone of the city, during February 2005. Anti-parvovirus B19 IgG antibodies were found in 172 (71.6%) pregnant women (CI 95% 65.5%-77.7%); this antibody prevalence is similar to results found for others Brazilian cities. The only variable associated with previous acquisition of IgG antibodies to parvovirus B19 was number of pregnancies greater than one (p= 0.02, CI 95% 0.36-0.94).
authors.affiliation: Instituto Fernandes Figueira da Fundação Oswaldo Cruz, Rio de Janeiro, RJ. andrericardo@hucff.ufrj.br
authors.forename: André Ricardo Araujo
authors.initials: AR
authors.lastname: da Silva
authors.forename: Susie Andries
authors.initials: SA
authors.lastname: Nogueira
authors.forename: Júlio Cezar Laura
authors.initials: JC
authors.lastname: Alzeguir
authors.forename: Maria Célia Freitas Leite
authors.initials: MC
authors.lastname: da Costa
authors.forename: Jussara Pereira
authors.initials: JP
authors.lastname: do Nascimento
mesh_terms: D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D001938:Brazil / Q000453:epidemiology; D005260:Female; D006801:Humans; D015160:Hydrops Fetalis / Q000175:diagnosis / Q000453:epidemiology / Q000821:virology*; D007074:Immunoglobulin G / Q000097:blood; D008875:Middle Aged; D010322:Parvoviridae Infections / Q000175:diagnosis / Q000453:epidemiology*; D016732:Parvovirus B19, Human / Q000276:immunology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000453:epidemiology / Q000821:virology*; D015995:Prevalence; D012307:Risk Factors
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G